Co-morbidities

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
CardioNerds @AHA23: An Extended Duration Short-Interfering RNA Targeting Lp(a)

Steven E Nissen, Maryam Barkhordarian,

Watch time: 9m 14s
HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell,

Watch time: 3m 56s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
Radcliffe & CardioNerds @AHA22: IRONMAN: Intravenous Ferric Derisomaltose in HF With Reduced EF

Rawan Amir, Paul Kalra,

Watch time: 18m 58s

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss,

Watch time: 18m 1s
Insights from EMPA-Kidney: Methodology, Data & Impact

Kate Wilcox, David Preiss,

Watch time: 38m 47s

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 5m 18s (6 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 7h 25m 37s (31 videos)

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Paul Kalra,

Watch time: 12m 41s (2 videos)
The PRESERVED-HF Study

Mikhail Kosiborod,

Watch time: 12m 4s

Rami Khayat , Andrew Pederzoli , William T Abraham ,

Saumil R Shah , Sergio Waxman , William H Gaasch ,

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s
ACC 2021 Discussion: The LIFE Trial

Harriette Van Spall, Douglas L Mann,

Watch time: 11m 30s

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
Radcliffe & CardioNerds @AHA22: IRONMAN: Intravenous Ferric Derisomaltose in HF With Reduced EF

Rawan Amir, Paul Kalra,

Watch time: 18m 58s

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Paul Kalra,

Watch time: 12m 41s (2 videos)

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 5m 18s (6 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann,

Watch time: 22m 15s
Association Between AID/FID with Incident CV Disease and Mortality

Benedikt Schrage,

Watch time: 5m 31s
The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)
The PRESERVED-HF Study

Mikhail Kosiborod,

Watch time: 12m 4s

Media

Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
HFA 2020: Prospective analysis of DAPA-HF

Watch time: 6m 52s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
CardioNerds @AHA23: An Extended Duration Short-Interfering RNA Targeting Lp(a)

Steven E Nissen, Maryam Barkhordarian,

Watch time: 9m 14s

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Aarti Asnani,

Watch time: 54m
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

Fausto J Pinto, John Spertus, , et al

Watch time: 16h 19m 46s (19 videos)
HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell,

Watch time: 3m 56s

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 7h 25m 37s (31 videos)

Articles

COVID-19 Pandemic and Cardiovascular Disease

Aniket S Rali

,

Andrew J Sauer

,

Published:

25 March 2020

Citation:

US Cardiology Review 2020;14:e01.

DOI:

https://doi.org/10.15420/usc.2020.14
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1239
  • Downloads: Downloads 31
  • Citations: 10
  • Read time: 15m

Impact of Atrial Septal Defect on Hemodynamics

Saumil R Shah

,

Sergio Waxman

,

William H Gaasch

,

Citation:

US Cardiology Review 2017;11(2):72–4.

DOI:

https://doi.org/10.15420/ucs.2017:9:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4926
  • Downloads: Downloads 26
  • Citations: 4

Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnea in Heart Failure

Sitaramesh Emani

,

William T Abraham

,

Citation:

US Cardiology 2012;9(1):53-6

DOI:

https://doi.org/10.15420/usc.2012.9.1.53
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1014
  • Downloads: Downloads 3
  • Citations: 1

Central Sleep Apnea in Heart Failure

Rami Khayat

,

Andrew Pederzoli

,

William T Abraham

,

Citation:

US Cardiology 2009;6(2):72–8

DOI:

https://doi.org/10.15420/usc.2009.6.2.72
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 6229
  • Downloads: Downloads 11
  • Citations: 4